Systematic Financial Management’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $495K | Sell |
1,690
-55
| -3% | -$18.1K | 0.01% | 233 |
|
|
2025
Q4 | $612K | Buy |
1,745
+185
| +12% | +$62.5K | 0.01% | 228 |
|
|
2025
Q3 | $504K | Sell |
1,560
-200
| -11% | -$62.2K | 0.01% | 222 |
|
|
2025
Q2 | $685K | Hold |
1,760
| – | – | 0.02% | 210 |
|
|
2025
Q1 | $766K | Hold |
1,760
| – | – | 0.02% | 204 |
|
|
2024
Q4 | $649K | Buy |
1,760
+795
| +82% | +$333K | 0.02% | 217 |
|
|
2024
Q3 | $502K | Sell |
965
-421
| -30% | -$225K | 0.01% | 269 |
|
|
2024
Q2 | $751K | Hold |
1,386
| – | – | 0.02% | 211 |
|
|
2024
Q1 | $719K | Buy |
1,386
+1,350
| +3,750% | +$671K | 0.02% | 213 |
|
|
2023
Q4 | $17K | Hold |
36
| – | – | ﹤0.01% | 231 |
|
|
2023
Q3 | $15.7K | Hold |
36
| – | – | ﹤0.01% | 230 |
|
|
2023
Q2 | $16K | Hold |
36
| – | – | ﹤0.01% | 223 |
|
|
2023
Q1 | $16.6K | Hold |
36
| – | – | ﹤0.01% | 294 |
|
|
2022
Q4 | $18.5K | Hold |
36
| – | – | ﹤0.01% | 229 |
|
|
2022
Q3 | $16K | Hold |
36
| – | – | ﹤0.01% | 227 |
|
|
2022
Q2 | $17K | Hold |
36
| – | – | ﹤0.01% | 229 |
|
|
2022
Q1 | $18K | Hold |
36
| – | – | ﹤0.01% | 231 |
|
|
2021
Q4 | $17K | Hold |
36
| – | – | ﹤0.01% | 234 |
|
|
2021
Q3 | $13K | Hold |
36
| – | – | ﹤0.01% | 233 |
|
|
2021
Q2 | $14K | Hold |
36
| – | – | ﹤0.01% | 236 |
|
|
2021
Q1 | $13K | Hold |
36
| – | – | ﹤0.01% | 229 |
|
|
2020
Q4 | $12K | Hold |
36
| – | – | ﹤0.01% | 230 |
|
|
2020
Q3 | $10K | Hold |
36
| – | – | ﹤0.01% | 233 |
|
|
2020
Q2 | $9K | Sell |
36
-22
| -38% | -$5.87K | ﹤0.01% | 495 |
|
|
2020
Q1 | $13K | Hold |
58
| – | – | ﹤0.01% | 466 |
|
|
2019
Q4 | $18K | Sell |
58
-103
| -64% | -$28.3K | ﹤0.01% | 473 |
|
|
2019
Q3 | $39K | Sell |
161
-6,599
| -98% | -$1.81M | ﹤0.01% | 502 |
|
|
2019
Q2 | $1.91M | Sell |
6,760
-1,214
| -15% | -$332K | 0.07% | 196 |
|
|
2019
Q1 | $2.29M | Sell |
7,974
-2,673
| -25% | -$773K | 0.08% | 232 |
|
|
2018
Q4 | $2.8M | Sell |
10,647
-1,315
| -11% | -$362K | 0.09% | 237 |
|
|
2018
Q3 | $3.28M | Sell |
11,962
-257
| -2% | -$66.7K | 0.08% | 257 |
|
|
2018
Q2 | $2.91M | Sell |
12,219
-210
| -2% | -$48.6K | 0.07% | 251 |
|
|
2018
Q1 | $2.73M | Sell |
12,429
-118
| -0.9% | -$27.7K | 0.06% | 253 |
|
|
2017
Q4 | $2.82M | Sell |
12,547
-754
| -6% | -$161K | 0.06% | 248 |
|
|
2017
Q3 | $2.53M | Sell |
13,301
-717
| -5% | -$136K | 0.05% | 253 |
|
|
2017
Q2 | $2.64M | Sell |
14,018
-762
| -5% | -$137K | 0.05% | 315 |
|
|
2017
Q1 | $2.44M | Buy |
+14,780
| New | +$2.35M | 0.04% | 314 |
|
|
2015
Q3 | – | Sell |
-3,580
| Closed | -$587K | – | 661 |
|
|
2015
Q2 | $587K | Sell |
3,580
-570,704
| -99% | -$91.2M | 0.01% | 628 |
|
|
2015
Q1 | $88.7M | Sell |
574,284
-324,460
| -36% | -$46.2M | 0.7% | 40 |
|
|
2014
Q4 | $113M | Buy |
898,744
+428,035
| +91% | +$52.9M | 0.83% | 24 |
|
|
2014
Q3 | $56.3M | Buy |
+470,709
| New | +$54M | 0.41% | 85 |
|
Other funds holding ELV
VCM
VPM
Systematic Financial Management's ELV Position: Q1 2026 in Review
Systematic Financial Management reduced its Elevance Health (ELV) stake by 3.2% in Q1 2026, selling an estimated $18.1K and leaving 1,690 shares worth $495K. The position accounts for 0.01% of the portfolio, ranked #233.
Systematic Financial Management first reported a position in ELV in Q3 2014 and has held it in 41 quarters since. The position peaked at $113M in Q4 2014. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- Systematic Financial Management held 1,690 shares of Elevance Health worth $495K as of Q1 2026.
- Systematic Financial Management sold 55 Elevance Health shares in Q1 2026, an estimated $18.1K.
- Elevance Health made up 0.01% of Systematic Financial Management's portfolio in Q1 2026, its #233 holding.
- Systematic Financial Management first reported a position in Elevance Health in Q3 2014 and has held it in 41 quarters since.
- Systematic Financial Management's Elevance Health position peaked at $113M in Q4 2014.
- 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on Systematic Financial Management's 13F filing for Q1 2026, filed 13 May 2026.